glp 1 with medicaid Save on GLP-1s SingleCare if won't cover them Medicare, Medicaid will cover GLP-1

Increased oxidative stress markers May be a promising indicator of risk for primary ovarian insufficiency: a cross-sectional case control study

Using them too soon prevents proper hormonal reset

Mild side effects, such as redness at the injection site, are possible, but serious side effects are rare

10.1038/s41586-021-03539-7 80

Subcutaneous injection may produce localized redness, minor swelling, or bruising at the injection site, which resolves within 24 to 48 hours

Patients considering compounded GLP-1 options should discuss the distinction between compounded and FDA-approved medications with a licensed provider before beginning treatment